Literature DB >> 19465419

'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis.

L M Woods1, B Rachet, P C Lambert, M P Coleman.   

Abstract

BACKGROUND: Although survival from breast cancer has greatly improved over the past three decades, there is little consensus as to whether a population of women diagnosed with breast cancer can ever be considered 'cured' of the disease. PATIENTS AND METHODS: We examined population 'cure' among women aged 15-99 years diagnosed with breast cancer from 1980 to 1995 in the West Midlands (England) and New South Wales (Australia). We calculated interval-specific excess mortality rates and fitted a number of statistical models to evaluate 'cure'.
RESULTS: There was little evidence that these women could ever be considered cured of the disease because excess mortality due to breast cancer was evident among young and middle-aged women up to 23 years after their diagnosis. Older women diagnosed in New South Wales displayed some evidence of 'cure'. However, this was estimated to occur only after the women's 75th birthday.
CONCLUSIONS: There is no strong evidence of the existence of a 'cured' subpopulation among young or middle-aged women diagnosed with breast cancer in either West Midlands or New South Wales during the period 1980-1995. Additional follow-up data would permit 'cure' to be assessed for women diagnosed more recently than 1995.

Entities:  

Mesh:

Year:  2009        PMID: 19465419     DOI: 10.1093/annonc/mdn791

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  11 in total

1.  Conditional survival in Canada: adjusting patient prognosis over time.

Authors:  H Bryant; G Lockwood; R Rahal; L Ellison
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

2.  Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

Authors:  Marco Colleoni; Zhuoxin Sun; Karen N Price; Per Karlsson; John F Forbes; Beat Thürlimann; Lorenzo Gianni; Monica Castiglione; Richard D Gelber; Alan S Coates; Aron Goldhirsch
Journal:  J Clin Oncol       Date:  2016-01-19       Impact factor: 44.544

3.  Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.

Authors:  Margaret R Stedman; Eric J Feuer; Angela B Mariotto
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

4.  Level of education, background and clinical stage as prognostic factors according to RMST function in patients with early and locally advanced breast cancer: a single institution experience from Romania.

Authors:  Irina Niţă; Cornelia Niţipir; Ştefania Andreea Toma; Alexandra Maria Limbău; Edvina Pirvu; Ioana Anca Bădărău; Ioana Suciu; George Suciu; Loredana Sabina Cornelia Manolescu
Journal:  Med Pharm Rep       Date:  2022-01-31

5.  Bayesian design of a survival trial with a cured fraction using historical data.

Authors:  Matthew A Psioda; Joseph G Ibrahim
Journal:  Stat Med       Date:  2018-06-25       Impact factor: 2.373

6.  Time-varying effects of prognostic factors associated with long-term survival in breast cancer.

Authors:  Minlu Zhang; Peng Peng; Kai Gu; Hui Cai; Guoyou Qin; Xiao Ou Shu; Pingping Bao
Journal:  Endocr Relat Cancer       Date:  2018-02-22       Impact factor: 5.678

7.  Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types.

Authors:  L Dal Maso; S Guzzinati; C Buzzoni; R Capocaccia; D Serraino; A Caldarella; A P Dei Tos; F Falcini; M Autelitano; G Masanotti; S Ferretti; F Tisano; U Tirelli; E Crocetti; R De Angelis; S Virdone; A Zucchetto; A Gigli; S Francisci; P Baili; G Gatta; M Castaing; R Zanetti; P Contiero; E Bidoli; M Vercelli; M Michiara; M Federico; G Senatore; F Pannozzo; M Vicentini; A Bulatko; D R Pirino; M Gentilini; M Fusco; A Giacomin; A C Fanetti; R Cusimano
Journal:  Ann Oncol       Date:  2014-08-22       Impact factor: 32.976

8.  Model-based Recursive Partitioning for Survival of Iranian Female Breast Cancer Patients: Comparing with Parametric Survival Models.

Authors:  Mozhgan Safe; Javad Faradmal; Jalal Poorolajal; Hossein Mahjub
Journal:  Iran J Public Health       Date:  2017-01       Impact factor: 1.429

9.  Long-term crude probabilities of death among breast cancer patients by age and stage: a population-based survival study in Northeastern Spain (Girona-Tarragona 1985-2004).

Authors:  R Clèries; A Ameijide; M Buxó; J M Martínez; R Marcos-Gragera; M-L Vilardell; M Carulla; Y Yasui; M Vilardell; J A Espinàs; J M Borràs; J Galceran; À Izquierdo
Journal:  Clin Transl Oncol       Date:  2018-03-06       Impact factor: 3.405

10.  No 'cure' within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989-2011.

Authors:  L M Woods; M Morris; B Rachet
Journal:  Ann Oncol       Date:  2016-08-29       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.